BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horvath Z, Saiko P, Illmer C, Madlener S, Hoechtl T, Bauer W, Erker T, Jaeger W, Fritzer-Szekeres M, Szekeres T. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. Exp Hematol 2005;33:329-35. [PMID: 15730856 DOI: 10.1016/j.exphem.2004.11.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Krawczyk H. The stilbene derivatives, nucleosides, and nucleosides modified by stilbene derivatives. Bioorg Chem 2019;90:103073. [PMID: 31234131 DOI: 10.1016/j.bioorg.2019.103073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
2 Huang XT, Li X, Xie ML, Huang Z, Huang YX, Wu GX, Peng ZR, Sun YN, Ming QL, Liu YX, Chen JP, Xu SN. Resveratrol: Review on its discovery, anti-leukemia effects and pharmacokinetics. Chem Biol Interact 2019;306:29-38. [PMID: 30954463 DOI: 10.1016/j.cbi.2019.04.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 10.8] [Reference Citation Analysis]
3 Chan CN, Trinité B, Levy DN. Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene. Antimicrob Agents Chemother 2017;61:e00408-17. [PMID: 28652233 DOI: 10.1128/AAC.00408-17] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
4 Graser-Loescher G, Schoenhuber A, Ciglenec C, Eberl S, Krupitza G, Mader RM, Jadav SS, Jayaprakash V, Fritzer-Szekeres M, Szekeres T, Saiko P. Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine. Food Chem Toxicol 2017;108:53-62. [PMID: 28716444 DOI: 10.1016/j.fct.2017.07.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
5 da Silva MM, Comin M, Duarte TS, Foglio MA, de Carvalho JE, do Vieira MC, Formagio AS. Synthesis, antiproliferative activity and molecular properties predictions of galloyl derivatives. Molecules 2015;20:5360-73. [PMID: 25816079 DOI: 10.3390/molecules20045360] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
6 Saiko P, Steinmann MT, Schuster H, Graser G, Bressler S, Giessrigl B, Lackner A, Grusch M, Krupitza G, Bago-Horvath Z, Jaeger W, Fritzer-Szekeres M, Szekeres T. Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine. Phytomedicine 2015;22:213-22. [PMID: 25636891 DOI: 10.1016/j.phymed.2014.11.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
7 Heredia A, Davis C, Amin MN, Le NM, Wainberg MA, Oliveira M, Deeks SG, Wang LX, Redfield RR. Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1. AIDS 2014;28:317-23. [PMID: 24326355 DOI: 10.1097/QAD.0000000000000168] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
8 Lee YJ, Park IS, Lee YJ, Shim JH, Cho MK, Nam HS, Park JW, Oh MH, Lee SH. Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53. Food Chem Toxicol 2014;63:153-60. [PMID: 24239893 DOI: 10.1016/j.fct.2013.11.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
9 Saiko P, Graser G, Giessrigl B, Steinmann MT, Schuster H, Lackner A, Grusch M, Krupitza G, Jaeger W, Somepalli V, Golakoti T, Fritzer-Szekeres M, Szekeres T. Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells. Invest New Drugs 2013;31:1115-24. [PMID: 23943154 DOI: 10.1007/s10637-013-0009-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
10 Heredia A, Davis CE, Reitz MS, Le NM, Wainberg MA, Foulke JS, Wang LX, Redfield RR. Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1. J Infect Dis 2013;208:2085-94. [PMID: 23922365 DOI: 10.1093/infdis/jit395] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
11 Vinod BS, Maliekal TT, Anto RJ. Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance. Antioxid Redox Signal 2013;18:1307-48. [PMID: 22871022 DOI: 10.1089/ars.2012.4573] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 9.4] [Reference Citation Analysis]
12 Verma S, Singh A, Mishra A. Gallic acid: molecular rival of cancer. Environ Toxicol Pharmacol 2013;35:473-85. [PMID: 23501608 DOI: 10.1016/j.etap.2013.02.011] [Cited by in Crossref: 197] [Cited by in F6Publishing: 209] [Article Influence: 19.7] [Reference Citation Analysis]
13 Saiko P, Graser G, Madlener S, Schwarz S, Krupitza G, Jaeger W, Somepalli V, Golakoti T, Fritzer-Szekeres M, Szekeres T. Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells. Nucleosides Nucleotides Nucleic Acids 2011;30:1190-6. [PMID: 22132974 DOI: 10.1080/15257770.2011.596497] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Szekeres T, Saiko P, Fritzer-szekeres M, Djavan B, Jäger W. Chemopreventive effects of resveratrol and resveratrol derivatives: Chemopreventive effects of resveratrol. Annals of the New York Academy of Sciences 2011;1215:89-95. [DOI: 10.1111/j.1749-6632.2010.05864.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 7.0] [Reference Citation Analysis]
15 Jäger W, Gruber A, Giessrigl B, Krupitza G, Szekeres T, Sonntag D. Metabolomic Analysis of Resveratrol-Induced Effects in the Human Breast Cancer Cell Lines MCF-7 and MDA-MB-231. OMICS: A Journal of Integrative Biology 2011;15:9-14. [DOI: 10.1089/omi.2010.0114] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
16 Saiko P, Graser G, Giessrigl B, Lackner A, Grusch M, Krupitza G, Basu A, Sinha BN, Jayaprakash V, Jaeger W, Fritzer-szekeres M, Szekeres T. A novel N-hydroxy-N′-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C). Biochemical Pharmacology 2011;81:50-9. [DOI: 10.1016/j.bcp.2010.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
17 Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, Jäger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T, Krupitza G. Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro. Br J Cancer 2010;102:1361-70. [PMID: 20424615 DOI: 10.1038/sj.bjc.6605656] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
18 Szekeres T, Fritzer-Szekeres M, Saiko P, Jäger W. Resveratrol and resveratrol analogues--structure-activity relationship. Pharm Res 2010;27:1042-8. [PMID: 20232118 DOI: 10.1007/s11095-010-0090-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
19 Kraft TE, Parisotto D, Schempp C, Efferth T. Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol. Critical Reviews in Food Science and Nutrition 2009;49:782-99. [DOI: 10.1080/10408390802248627] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
20 Heffeter P, Popovic-Bijelic A, Saiko P, Dornetshuber R, Jungwirth U, Voevodskaya N, Biglino D, Jakupec MA, Elbling L, Micksche M, Szekeres T, Keppler BK, Gräslund A, Berger W. Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772). Curr Cancer Drug Targets 2009;9:595-607. [PMID: 19508176 DOI: 10.2174/156800909789056962] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
21 Guerrero RF, García-parrilla MC, Puertas B, Cantos-villar E. Wine, Resveratrol and Health: A Review. Natural Product Communications 2009;4:1934578X0900400. [DOI: 10.1177/1934578x0900400503] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
22 Bernhaus A, Fritzer-Szekeres M, Grusch M, Saiko P, Krupitza G, Venkateswarlu S, Trimurtulu G, Jaeger W, Szekeres T. Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells. Cancer Lett 2009;274:299-304. [PMID: 18952370 DOI: 10.1016/j.canlet.2008.09.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
23 Pezzuto JM. Resveratrol as an Inhibitor of Carcinogenesis. Pharmaceutical Biology 2008;46:443-573. [DOI: 10.1080/13880200802116610] [Cited by in Crossref: 64] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
24 Miksits M, Maier-salamon A, Aust S, Thalhammer T, Reznicek G, Kunert O, Haslinger E, Szekeres T, Jaeger W. Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 2008;35:1101-19. [DOI: 10.1080/00498250500354253] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 4.6] [Reference Citation Analysis]
25 Flanagan SA, Gandhi V, Meckling KA. Guanosine acts intracellularly to initiate apoptosis in NB4 cells: A role for nucleoside transport. Leuk Lymphoma 2007;48:1816-27. [PMID: 17786719 DOI: 10.1080/10428190701528491] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
26 Kaindl U, Eyberg I, Rohr-Udilova N, Heinzle C, Marian B. The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage. Food Chem Toxicol 2008;46:1320-6. [PMID: 17936464 DOI: 10.1016/j.fct.2007.09.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
27 Saiko P, Szakmary A, Jaeger W, Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 2008;658:68-94. [PMID: 17890139 DOI: 10.1016/j.mrrev.2007.08.004] [Cited by in Crossref: 334] [Cited by in F6Publishing: 345] [Article Influence: 20.9] [Reference Citation Analysis]
28 Stervbo U, Vang O, Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif 2006;39:479-93. [PMID: 17109633 DOI: 10.1111/j.1365-2184.2006.00406.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
29 Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224:274-283. [PMID: 17306316 DOI: 10.1016/j.taap.2006.12.025] [Cited by in Crossref: 495] [Cited by in F6Publishing: 513] [Article Influence: 30.9] [Reference Citation Analysis]
30 Horvath Z, Murias M, Saiko P, Erker T, Handler N, Madlener S, Jaeger W, Grusch M, Fritzer-Szekeres M, Krupitza G, Szekeres T. Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Exp Hematol 2006;34:1377-84. [PMID: 16982330 DOI: 10.1016/j.exphem.2006.05.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
31 Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58:621-681. [PMID: 16968952 DOI: 10.1124/pr.58.3.10] [Cited by in Crossref: 3327] [Cited by in F6Publishing: 3485] [Article Influence: 195.7] [Reference Citation Analysis]
32 Li Y, Moysich KB, Baer MR, Weiss JR, Brasure J, Graham S, McCann SE. Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leuk Res. 2006;30:1507-1515. [PMID: 16678899 DOI: 10.1016/j.leukres.2006.03.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
33 Madlener S, Illmer C, Horvath Z, Saiko P, Losert A, Herbacek I, Grusch M, Elford HL, Krupitza G, Bernhaus A. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett. 2007;245:156-162. [PMID: 16488533 DOI: 10.1016/j.canlet.2006.01.001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 5.6] [Reference Citation Analysis]